Founder/CEO, Dr. Zhijian Yang
-
An entrepreneur in the biomedical business who has successfully initiated and founded several biotech companies.
-
Over 20 years of working experience in overseas biotech companies.
-
Served as head of the R&D Division at AntiCancer Inc. in the USA, a Contract Research Organization focusing on cancer biology and animal modeling.
-
Expertise in orthotopic tumor animal models and non-invasive animal imaging technology.
-
Rich experience in company stratification, resourcing, management, and business operations within a biomedical CRO.
-
Specialized in orthotopic tumor disease animal models, large animal functional testing, and the development and application of new animal imaging technologies.
-
Published several research papers in international academic journals, including Cancer Research and Clinical Cancer Research.
Founder/CSO, Dr. WenQing Yang
-
Ph.D. in Cell Biology; Postdoctoral Fellowship in Cancer Biology, University of Calgary, Canada.
-
30+ years of experience in translational research in the fields of Oncology, Cancer Immunotherapy, Autoimmune, and CNS diseases with top-tier pharmaceutical companies and CROs, e.g. Amgen, BMS/Celgene, CrownBio, and Simcere Pharmaceutical Group.
-
Past leadership roles include Senior Director, Executive Director, and Head of the Translational Research Institute.
-
Established and chaired the Translational Science Division, spearheading efforts to advance diverse pipelines at Simcere Pharma Group.
-
Developed cutting-edge translational oncology capabilities and provided leadership to the Cancer Pharmacology/Cancer Biology Divisions at Crown Biosciences.
-
Long-term translational efforts have led to more than 25 INDs and several late-stage clinical trials approved by the FDA or CDE.
-
Authored 100+ research publications and serve as an Editor/Editorial Board Member for 7 international peer-reviewed journals.
联科
Official Public Number
Copyright©2023 Nanjing Yunqiao Purui Biotechnology Co., Ltd.
